TOPPAN Holdings Establishes New Company for Cancer Personalized Medicine in the US
NQ Score
42/100
N1 Content Completeness
4
AI Summary (NQ-processed)
TOPPAN Holdings established "TOPPAN Global Medical Healthcare Inc." in Houston, Texas, in March 2026, to advance personalized cancer medicine and drug discovery support. Leveraging its proprietary 3D cell culture technology "invivoid®", the new company will accelerate R&D and local collaborations at the Texas Medical Center, aiming for the societal implementation of personalized medicine.